Operation Warp Speed redux: HHS awards $1.4B to develop next-gen Covid-19 drugs and vaccines
HHS on Tuesday announced it’s pumping $1.4 billion in government funds into next-gen Covid-19 medical products in the pipeline, including $326 million to Regeneron to help develop a Covid-19 monoclonal antibody.
The announcement is the first public step forward for Project NextGen, which aims to spend $5 billion on developing new Covid-19 therapies and vaccines, the Biden administration announced in May.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.